Gains in childhood cancer survival slow

02/19/2013 | Bloomberg Businessweek

Although the five-year survival rate of children with cancer increased from 30% in the 1960s to 80% in the 2000s, improvement has leveled off, physicians wrote in Lancet Oncology. The report's authors say the approach to research and regulation must be modernized to address the issue. Just 15 childhood cancer drugs have been allowed for use in children since 1998.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA